Updated:
United Mitochondrial Disease Foundation
United Mitochondrial Disease Foundation funds mitochondrial disease research and patient support.
United Mitochondrial Disease Foundation
The United Mitochondrial Disease Foundation is based in Pittsburgh, Pennsylvania. It focuses on research and education for mitochondrial disorders, as well as providing support to affected individuals and families. The foundation made a single investment, in NAPIGEN, as part of a Seed VC round on July 12, 2022.
General information
Firm type
Foundation
Year founded
1996
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pittsburgh
Corporate office
Pittsburgh, PA, United States
Principals
David B. Voran
President and CEO
Catherine A. Brissette
Board Chair
Sector focus
Frequently asked questions
Who runs investment decisions at the United Mitochondrial Disease Foundation?
Day-to-day operations are led by President and CEO David B. Voran, who joined UMDF in 2017 from the Muscular Dystrophy Association. Research grant allocation is overseen by a scientific advisory board of mitochondrial medicine experts. Board Chair Catherine Brissette provides governance oversight (per UMDF official communications).
How does UMDF source research opportunities?
UMDF issues competitive grant cycles for basic and translational science, reviewed by its scientific advisory board. It also funds specific initiatives through partnerships with academic institutions such as Children's Hospital of Philadelphia and UC San Diego. The foundation's annual symposium serves as a convening point for researchers and clinicians (per UMDF annual reports).
Is UMDF structured as a patient advocacy organization, a research foundation, or both?
UMDF operates as both a patient advocacy group and a research funding foundation. It provides direct support to patients and families via a helpline, educational resources, and an annual conference. Separately, it awards research grants for mitochondrial disease. This dual structure is uncommon among disease foundations (per UMDF website).
Does UMDF invest in venture capital or equity deals?
No. UMDF is a traditional non-profit foundation that allocates capital through research grants and contracts, not equity investments. It does not participate in venture deals or direct company funding. Its assets are managed conservatively for operational sustainability (per UMDF annual reports).
What investment types does UMDF fund?
UMDF funds research grants focused on mitochondrial disease, including gene therapy, metabolic interventions, biomarker discovery, and natural history studies. It also sponsors clinical trials at academic medical centers. The foundation does not fund for-profit entities or direct commercialization efforts (per UMDF grant guidelines).
Which sectors does UMDF explicitly avoid?
UMDF does not fund for-profit companies, venture capital, real estate, or any investment unrelated to mitochondrial disease research. Its sole mission is to advance scientific understanding and treatment of mitochondrial disorders (per UMDF website).
Where does UMDF's funding come from?
UMDF's funding comes from individual donations, corporate sponsorships (including pharmaceutical companies), and fundraising events. It does not rely on a single wealthy family or endowment. The foundation's public 990 filings detail revenue streams from contributions and program service revenue (per UMDF IRS Form 990).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: